357TiP SGNLVA-002: Single arm, open-label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of triple-negative breast cancer
J. Cortés
◽
S. Diab
◽
R.K. Basho
◽
M. Oliveira
◽
T. Pluard
◽
...
2019 ◽
Vol 30
◽
pp. iii63
V. Boni
◽
C. Alemany
◽
J.L. Meisel
◽
R. Sinha
◽
D. Sterrenberg
◽
...
Hyo (Heather) Han
◽
Sami Diab
◽
Carlos Alemany
◽
Reva Basho
◽
Ursa Brown-Glaberman
◽
...
Biyun Wang
◽
Tao Sun
◽
Yannan Zhao
◽
Shusen Wang
◽
Jian Zhang
◽
...
Biyun Wang
◽
Tao Sun
◽
Yannan Zhao
◽
Shusen Wang
◽
Jian Zhang
◽
...
X. Hu
◽
B. Wang
◽
J. Zhang
◽
Z. Wang
◽
T. Sun
◽
...
A. Brufsky
◽
S.B. Kim
◽
Ž. Zvirbule
◽
A. Eniu
◽
J. Mebis
◽
...
2013 ◽
Vol 59
(3)
◽
pp. 207-213
◽
Yuqian Liao
◽
Ying Fan
◽
Yiye Wan
◽
Jun Li
◽
Lixiang Peng
Peter Schmid
◽
Javier Cortes
◽
Mark Robson
◽
Hiroji Iwata
◽
Roberto Hegg
◽
...
P Schmid
◽
AT Nunes
◽
R Lall
◽
C D'Cruz
◽
L Grinsted
◽
...
Close
Export Citation Format
Close
Share Document
Close